Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -4.93% |
|
+1.42% | -89.56% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.56% | 66.52M | |
+38.65% | 39.1B | |
-7.57% | 38.76B | |
+27.51% | 31.24B | |
+13.26% | 25.9B | |
-13.50% | 25.8B | |
+45.33% | 14.06B | |
+39.56% | 13.12B | |
-6.91% | 11.32B | |
-12.05% | 10.68B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- Oppenheimer Adjusts AN2 Therapeutics Price Target to $20 From $22, Maintains Outperform Rating